ArticleMolecular cancer therapeutics2024

The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading.

Niranjan Sudhakar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.